Manganese (Mn) is a trace element essential for brain development and functioning of the central nervous system. However, there is a lack of information concerning the neurotoxicity of Mn under realistic doses in early stages of development, though excess of Mn results in a progressive disorder of the nervous system called manganism. In the current study, adult mice were exposed to three doses of Mn for 60 days through daily gavages, while mice pups were exposed to the same Mn doses during developmental period (gestational and breast-feeding). From the latter group of mice, a group was exposed for more 60 days to the same Mn doses. Chemical analysis revealed a dose-dependent bioaccumulation of Mn in mice's brain. Biochemical parameters revealed that (1) Mn affects non-protein thiol levels, glutathione S-tranferase and acetylcholinesterase activities, as well as the levels of oxidized lipids and proteins in mice brain, though lipids and proteins alterations were found only after exposure to high and unrealistic doses; (2) Realistic doses of Mn affects the activity of brain AChE and finally; (3) Pups' brain were affected by Mn even whether only the parental females had been previously exposed. The current study shows evidences of chemical stress in mice exposed to Mn during the early period of development and an efficient mechanism of Mn elimination under higher doses. These findings open new lines of investigation regarding manganese toxicity in vertebrates mainly in the early stages of development.
Introduction
Manganese (Mn) is an abundant transition metal essential to mammalian physiological processes (Santos et al., 2014) . Eleven chemical oxidation states are found, where di, tetra and heptavalent states are the most important for cell physiology. Particularly, Mn plays vital roles on the mitochondrial enzymes manganesesuperoxide dismutase (Mn-SOD), glutamine synthetase, alkaline phosphatase and arginase (Takeda and Avila, 1986) .
Mn uptake is more efficient by inhalation, but ingestion and skin surface are also potential routes. In general, a human (~70 kg) is exposed to about 2e9 mg Mn.day À1 mainly through food (Aschner et al., 1999) ; but according to Cornelis and Nordberg (2007) the level of exposure is higher if water and food contamination, due to human activities, is considered. According to Martinez-Finley et al. (2013) , an overexposure or accumulation of Mn causes a pathological state known as manganism. Perl and Olanow (2007) described this disturb as a consequence of increased production of reactive oxygen species and toxic metabolites, or depletion of cellular antioxidant defenses. The brain is particularly vulnerable to oxidative damage due to its high rate of oxygen consumption, intense production of reactive radicals and high levels of transition metals, such as iron and manganese. According to Ansari et al. (2008) , both metals can catalyze the production of the very toxic hydroxyl radical (OH · ) through Fenton's reaction. Mitochondria, nucleus and synaptosomes of neuron and astrocytes of globus pallidus are described as the primary sites of Mn accumulation and toxicity in the brain (Martinez-Finley et al., 2013) . Additionally, many studies reported that the sub-clinical neurological effects are the decrease of intellectual functions and increased risk of mortality of infants during their first year of life (Hafeman et al., 2007) . The neurotoxicity of Mn is characterized by neuropsychiatric, cognitive, behavioral and motor disorders (Erikson et al., 2007; Perl and Olanow, 2007) . According to Mergler et al. (1999) , the most important effects in vertebrates are poor hand-eye coordination, motor slowing, increased tremor, reduced response speed, olfactory enhancement and mood changes with possible memory and intellectual deficits. Cholinergic afferents are crucial for locomotion, cognition, emotion and behavioral response, and, therefore, anatomical selectivity of most manganese-induced cholinergic effects is compatible with the clinical symptoms of manganism (Finkelstein et al., 2007) . Additionally, manganese influences astrocytic choline transport systems and astrocytic acetylcholinebinding proteins, affecting the reciprocal relationship between astrocytes and cholinergic neurons. A controversial point is whether the effects of manganese are more related to dopaminergic dysfunction in detriment of cholinergic one.
Neonates may be subject to a greater risk for Mn-induced neurotoxicity than adults (Torrente et al., 2002) , and Mn crosses the placenta barrier exposing fetal tissues (Domingo, 1994; Fechter, 1999) . Thus, in the current study, the neurological risk of exposure to manganese was investigated in mice chronically exposed to low daily doses of manganese as studies utilizing realistic doses in vertebrates are very scarce. Particularly, the effects of Mn at prenatal and breastfeeding periods were investigated through biochemical biomarkers in mice pups in order to elucidate some important aspects chemical stress in the early stages of development of vertebrates.
Material and methods

Animal manipulation
All experiments were conducted in accordance with the Ethics Animal Experiment Committee from Sector of Biological Sciences at Federal University of Paran a (protocol 467/2010) (http://www. bio. ufpr.br/portal/comissao-de-etica-para-o-uso-de-animais/) i n accordance with the experimental Animal Brazilian Council (COBIEA) and Guide for the Care and Use of Experimental Animals (Canadian Council on Animal Care).
Experimental design
Experiment I. In order to confirm the effect of manganese chloride in adults and validate the experimental design, twenty-oneday adult male mice (Swiss) were exposed to 0 (control), 7.5, 15 and 30 mg kg
À1
.day À1 of MnCl 2 through daily gavages during 60 days (n ¼ 15 mice per group). After exposure, the liver and brain were sampled to chemical and biochemical analyses. Experiment II. To evaluate the effects of low doses of manganese in adults and to compare the bioavailability of two different chemical forms, a group of twenty-one-day old male mice were exposed to 0 (control), 0.013, 0.13 and 1.3 mg kg
.day À1 of either manganese chloride or manganese acetate through daily gavages during 60 days. After this period, mice (n ¼ 15 per experimental group) were sacrificed by cervical dislocation, and the liver and brain were sampled to biochemical analyses. The intermediate dose was based on a potential human daily exposure to Mn (9 mg Mn/ 70 kg individual) (Aschner et al., 1999) . Experiment III. Initially, 21-day old male (n ¼ 5 per group) and female (n ¼ 10 per group) mice were exposed to 0 (control), 0.013, 0.13 and 1.3 mg kg
.day À1 of MnCl 2 through daily gavages during 60 days. For mating, male and female mice were placed together in a proportion of 1:2. Pregnant female mice continued to be exposed to the nominal MnCl 2 doses throughout pregnancy and breastfeeding periods. After weaning, fifteen mice pups per group were sacrificed by cervical dislocation for liver and brain sampling. The remaining pups were utilized in the experiment IV. Experiment IV. Mice puppies parentally exposed to MnCl 2 in Experiment III were exposed to 0 (control), 0.013, 0.13 and 1.3 mg kg
.day À1 of MnCl 2 through daily gavages during 60 days (n ¼ 15 mice per group). Then, the liver and brain were sampled to biochemical analyses.
Chemical procedures for manganese analysis
Sample extraction: the samples were lyophilized in a Terroni LD1500A lyophilizer. The extractions were carried out in triplicate in Microcontrolled digestion block Tecnal Model 40/25. Each sample extracted of about 0.3 g was weighed in analytical scales Shimadzu AY 220 in borosilicate with the addition of 10 ml nitric acid and left to rest for 2 h. Then, they were heated up to 120 C for 4 h. The extract obtained was transferred to 50 ml volumetric flasks through filtration in Whatman number 540 quantitative filter, followed by successive washing and assessment with ultrapure water after Reverse Osmosis procedure. The extracts were then stored under refrigeration at 4 C up to the reading.
Flame atomic absorption spectroscopy: the readings were carried out in the Flame Atomic Absorption Spectrometer e FAAS Varian, model 240FS, using the SIPS automatic dilution system, equipped with deuterium lamp background correction and Mn multielement hollow cathode lamp with 5.0 mA of current intensity, 279.5 nm wavelength and 0.2 nm fissure width. The ideal working band used was from 0.02 to 5.00 mg ml
À1
. An oxidant flame air/ acetylene was used, with 13.50 L min À1 and 2.00 L min À1 flow, respectively. In order to prepare the standard solution, the 1000 mg l À1 manganese stock solution Qhemis High Purity (PAMN 1000-0125) tracked by SRM/NIST-USA 928, prepared with ultrapure water. The analytical curve was built from this pattern at the concentration 1.00 mg l
, obtaining dilution at 0.75, 0.50, 0.25 and 0.00 mg l
. The correlation coefficient (r) obtained by analytical curve was 0.9987, with a value close to the reference value considered excellent (r ¼ 1.0000). The blank reading was carried out, where we calculated the limit of detection (LOD), the lowest concentration of analyte in a sample that can be detected, of 0.2988 mg l À1 (Eq I), and the limit of quantification (LOQ), the lowest concentration of analyte that can be determined with a reasonable degree of precision and accuracy, of 0.9963 mg l À1 (Eq II). After the analysis, results were converted into mass and used in each sample.
Where Sb: White analysis triplicate standard deviation b: Straight linear coefficient
Validation Method: the accuracy of the proposed method was verified from the certified reference material analysis ERM-CE278 (mussel tissue) from the European Measure and Reference Material Institute e IRMM. The method described revealed recovery of 90.2%, and the certified amount of Mn was 7.69 ± 0.23 mg g À1 while the amount obtained through the method was 6.94 ± 0.18 mg g À1 , showing that the method can be used as the matrix of this study.
Biochemical procedures
Samples of brain and liver were frozen and preserved at À76 C, thawed on ice bath and homogenized in 1.5 ml of phosphate buffered saline (PBS, pH 7.2, 4 C). Homogenates were centrifuged at 10,000 g for 20 min at 4 C and supernatants were used for biochemical analyses. Non-protein thiols concentration, represented mainly by glutathione, GSH (Sedlak and Lindsay, 1968) , lipid peroxidation (Jiang et al., 1991) , glutathione S-transferase activity (Keen et al., 1976) and protein content (Bradford, 1976) were measured according to modified protocols previously published by Moura Costa et al. (2010) . Acetylcholinesterase activity was measured according to Ellman et al. (1961) , whereas protein carbonyls were measured according to Levine et al. (1994) and Quinlan and Gutteridge (2000) .
Statistical procedures
Data were tested for normality and one-way analyses of variance (ANOVA) followed by Dunnett's post test (Mn exposed groups vs control) were used to determine significant differences. Values p < 0.05 were considered significant.
Results
No mortality or observable health problems were detected during the experiments.
Mice under lower doses of Mn tend to a higher bioaccumulation rate
Brain chemical analysis after exposure to higher doses of Mn showed increased dose-dependent bioaccumulation. The accumulation of the Mn in individuals exposed to 7.5, 15 39 mg kg À1 was 1.3, 1.49 and 1.69-fold the control level, respectively (Fig. 1) .
Chemical stress caused by manganese was confirmed under high doses
Mn affected all biochemical parameters evaluated in the brain of mice in the current study. Mice exposed to high doses of Mn (7.5, 15 and 30 mg kg
À1
.day À1 ) presented decreases of non-protein thiols (NPT) concentrations (respectively 58, 75 and 73%, Fig. 2A ) and a dose-dependent decrease of GST activity of respectively 42%, 46% and 59% (Fig. 2B ). These decreases correlate with the dosedependent increases of lipid peroxidation of 64, 109 and 121% in the brain of mice exposed to 7.5, 15 and 30 mg kg
.day À1 , respectively ( Fig. 2C ; r 2 ¼ 0.955 for NPT and r 2 ¼ 0.755 for GST; p < 0.05). Protein carbonylation increased 68, 85 and 80% at the same groups, although without a clear dose-response pattern (Fig. 2D) . However, Mn did not affect only the brain's oxidative parameters, acetylcholinesterase activity decreased 43, 56 and 55% Fig. 1 . Manganese bioaccumulation rates in the brain of adult mice after long-term exposure to high and daily doses of MnCl 2 . Mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. Fig. 2 . Biochemical parameters in the brain of mice exposed to 7.5, 15 and 30 mg kg
.day À1 of MnCl 2 during 60 days (Experiment I). Mean ± SD. **p < 0.01; ***p < 0.001. in mice exposed, respectively, after exposure to 7.5, 15 and 30 mg kg
.day À1 of Mn ( Fig. 2E ).
Realistic doses of Mn affected brain biomarkers, but not hepatic ones
As Mn affected all biochemical parameters evaluated in the current study, the effects of lower and realistic doses of two chemical formulations (Mn chloride and acetate) were investigated. Both chemical formulas showed very similar response patterns for GST activity (decreases of about 25% for chloride and 15% for acetate; Fig. 3AeB ), as well as lipid peroxidation and protein carbonylation (values similar to those of the control; Table 1 ). Nonprotein thiols concentration also decreased after exposure to the intermediate (37%) and the highest (40%) Mn acetate doses (Fig. 3C) , while for Mn chloride non-protein thiols also decreased, but only after exposure to the highest dose (49%; Fig. 3D ). Mn chloride was slightly more toxic than acetate concerning to acetylcholinesterase activity, since the lowest dose (0.013 mg kg
À1
.day À1 ) has been enough to lead to a 17% decrease of Fig. 3 . Biochemical parameters in the brain of mice exposed to 0.013, 0.13 and 1.3 mg kg
.day À1 of MnCl 2 or Mn acetate during 60 days (Experiment II). Mean ± SD. *p < 0.05; **p < 0.01; p***<0.001. activity (Fig. 3DeE) . As Mn chloride has been described as the most bioavailable formulation for humans, it was utilized to study the effects of manganese in the experiments III and IV. Finally, exposure of adult and newborn mice demonstrated that low realistic doses of Mn were not hepatotoxic concerning to oxidative stress (Table 2) .
Parental exposure to Mn affected brain biomarkers of mice pups
The response patterns of mice offspring exposed to Mn showed similar levels of non-protein thiols and GST activity of newborn mice exposed through parental via (Experiment III) in comparison with parental and trophic exposure (Experiment IV) (Fig. 4AeB) . Curiously, slight higher dose-dependent decreases were observed for mice exposed only during prenatal and breastfeeding periods. GST activities decreased 30% (vs 23%) and 38% (vs 30%) in the mice exposed to 0.13 and 1.3 mg kg
À1
.day
, respectively ( Fig. 4AeB) , whereas non-protein thiols concentrations decreased 33% (vs 30%), 51% (vs 33%) and 52% (vs 46%) in the mice exposed to 0.013, 0.13 and 1.3 mg kg
, respectively ( Fig. 4CeD) . For AChE, enzyme activities also decreased in mice pups exposed to Mn through parental via (Experiment III) in comparison to those exposed through parental and trophic exposure (Fig. 4EeF) . However, the former group was more affected by Mn, since this group showed a decrease of AChE activity at the lowest dose (18%). In addition, AChE activity decreases were harsher in this group, since decreases of 21% (vs 17%) and 27 (vs 14%) occurred in the mice exposed to 0.13 and 1.3 mg kg
.day À1 respectively (Fig. 4EeF) .
Discussion
The present study highlights the need to discuss the limits for manganese exposure in natural biota and human population. Particularly, the risk of exposure to Mn during critical neurodevelopment periods is poorly investigated (Erikson et al., 2007) . This issue is addressed in the current work by the investigation of neurological effects of Mn during early life stages and long-term of exposure.
Recently Santos et al. (2012) described that the AChE activity may serve as an early biomarker of Mn neurotoxicity and that cholinergic response are neurotoxic events induced by manganese. In the same year, Zarros et al. (2012) contested these findings describing that Mn exposure to rats is more related with an upregulation of AChE in the brain and cerebellum and not due to a downregulation, as reported by Santos and colleagues. According to Zarros and colleagues, the downregulation observed by Santos et al. (2012) was a consequence of the use of pentobarbital (20 mg/kg) to euthanize the rats, instead of decapitation. Our data show that it is a controversial position, since decreases of AChE activity in both adults and pulps occurred after Mn exposure, even though cervical dislocation was performed to euthanize the mice. Additionally, a more realistic exposure design was performed (low doses, oral and subchronic exposure). In this sense, the current data instigate new questions that must be further investigated in order to understand the chemical stress and neurotoxicity of Mn in vertebrates.
According to U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA), the levels of Mn should not exceed 0.05 mg l À1 in drinking water. But recent studies have showed that industrial sewage may reach values close to 2 mg l À1 of Mn, which is forty-fold higher (Santos et al., 2014 ). Yet, Martinez- Table 2 Biochemical parameters in the liver of mice exposed to manganese. GST expressed in mmol GSH-CDNB formed.min
À1
.mg prot
; NPT expressed in mmol de thiols.min et al. (2013) has reported that manganese half-life in mammals' brain is between 51 and 74 days. The current study tested doses based on these two reports to investigate a more realistic condition of manganese exposure. The chemical analysis in mice brain showed dose-dependent bioaccumulation rates, but although the highest dose of Mn was 4-fold the lowest, bioaccumulation was only 1.23-fold. A possible explanation could be the activation of a more efficient mechanism related to Mn elimination at higher doses. These data support that under lower doses the residual time of Mn increase and may lead to a potential toxicity at long-term exposure. These findings partially explain the current effects in individuals after long-term exposure.
Mn-induced oxidative stress in brain (Liccione and Maines, 1988; Huang et al., 2011) and the in vitro vulnerability of glial and neuronal cells to Mn (Rovettad et al., 2007) corroborate the current results and confirm the nervous tissue important primary target of Mn toxicity. Mn toxicity is more evident in developing brain, since this metal can cross the blood-brain barrier in pups more easily than in the adults. According to Markesbery (1997) , Normandin and Hazell (2002) and Aschner et al. (2007) , the excessive accumulation of Mn in the brain can lead to the development of a syndrome whose symptoms are similar to those of Parkinson's and Alzheimer's diseases. Normandin and Hazell (2002) described that Mn exposure can lead to selective dopaminergic dysfunction, neuronal loss, gliosis in basal ganglia and characteristic astrocytic changes known as Alzheimer Type II astrocytosis. These data are corroborated by Racette (2014) , that related Mn to Parkinson disease through dopaminergic dysfunction, but the present data showed Fig. 4 . Biochemical parameters in the brain of mice exposed to manganese through parental via only (Experiment III) and through parental via followed by 60 days of gavages (Experiment IV). Mean ± SD. *p < 0.05; **p < 0.01; p***<0.001. that cholinergic synapses are also an important target of Mn, mainly under low doses and long-term of exposure.
The alteration of all biochemical biomarkers in the brain of mice in the current study can have important impact on its function. According to Prabhakaran et al. (2009) and Huang et al. (2011) , Mn can participate of the Fenton's reaction, leading to the production of hydroxyl radical that is neutralized by GSH. Decrease of nonprotein thiols concentration, such as that observed in the current study, can therefore lead to oxidative stress, cell demise (Alexi et al., 2000; Ansari et al., 2004 Ansari et al., , 2008 and, ultimately, to brain lesions (Ansari et al., 2006) . Additionally, the depletion of GSH has been linked with various neurodegenerative diseases, described by Gegg et al. (2003) and already showed experimentally by Desole et al. (1995) or in patients with neurodegenerative diseases by Sian et al. (1994) .
GST is implicated in phase II biotransformation of various endogenous and xenobiotic compounds. According to Goodrich and Basu (2012) , mercury, cadmium, arsenic and manganese can interact and inhibit GST activity. The present study showed decreases of the levels of non-protein thiols such as GSH and decrease of GST activity after trophic and chronic exposure of mice to low as well as high doses of Mn. As consequences, dose-dependent damages in lipids and proteins (Experiment I) were observed at high doses of Mn, which overcame antioxidant defenses, but not at low, realistic doses (Experiment II). These data support the idea that mechanisms other than biomolecules damage are involved in the neurotoxicity of Mn at low doses but under long-term exposure. According to Xie et al. (1998) , several toxic lipid peroxidation products are formed during a prolonged oxidative stress, potentially resulting in neuronal death. In addition, Mn neurotoxicity has been associated with brain dopamine systems (Erikson et al., 2004) . In this case, catecholamines and other neurotransmitters are targets of oxidative modification (Villalobos et al., 2001 ) despite of the observed effects in lipids and proteins.
Acetylcholinesterase activity was impaired in the brain of mice exposed to low and high doses of manganese. Santos et al. (2012) have described similar effects in brain of rats, showing signs of neurobehavioral toxicity, whereas Milatovic et al. (2006) have reported the decrease of AChE activity in association with oxidative stress, changes in energy metabolism and neurodegeneration of pyramidal neurons. As confirmed by the current work, other studies revealed decrease of the AChE activity under higher doses (20e25 mg g À1 ) (Deskin et al., 1981; Santos et al., 2012) . For the first time, the present data highlights the impact of low doses of Mn on AChE activity in both, adult and pup mice, and so brain AChE activity could potentially be used as an early biomarker of Mn exposure and toxicity. Decrease of AChE activity can lead to overstimulation of acetylcholine receptors, due to accumulation of acetylcholine in the synaptic cleft, at central nervous system and, therefore, to physiological effects that include psychological disorders, disorientation, convulsions, respiratory depression and cardiovascular collapse (Boelsterli, 2007) . These effects occur depending on the level blocked enzyme; as rough overview, 10e20% inhibition cause mild symptoms, 50% massive symptoms and >90% is fatal (Boelsterli, 2007) .
Curiously, AChE activity decrease was almost similar in mice pups exposed to Mn through parental via (gestation and breastfeeding) and in those exposed through parental via followed by continued exposure to Mn through gavages. This finding may be better investigated as to elucidate whether the effect is due to Mn presence in the milk or if it is a real case of epigenetic heritage.
Conclusions
Despite of the well-described dopaminergic effects of Mn and a controversial position that cholinergic effects are related to the upregulation of AChE, Mn exposure can cause the decrease of AChE activity, if the mice are exposed to low doses and long-term of exposure. Data on effects of realistic doses of Mn during development, as well as to young and adult mice are important to understand the real risk of exposure to mammals. Additionally, the current study demonstrated that antioxidant defenses (non-protein thiols), GST activity and AChE activity are reliable biomarkers to evaluate the effects of low doses of Mn exposure in adults and young mice. These effects can be associated with manganism and neurodegenerative damages. Therefore, behavioral, cognitive and neuromotor effects may be better investigated for such realistic Mn exposures in both adults and young mammals.
